ABOUT US
Wuhan First Biotechnology Co. Inc. is a national high-tech enterprise specializing in the research, development, production and distribution of precision medical diagnostic instruments and related advanced assay reagents. Based on its advanced technology and innovation, FIRST is among the first-line producers of molecular assay instruments and pharmacogenetics in China.
With " Full Innovative Reliable Specified Technological" mission, and baesd on all of its indpendent innovation, First produces both molecular and immunological assay instruments in and related assay kits independently. In molecular discipline, FIRST develops full-line products, including antomated nucleic acid extractor, bee-bird quantitative PCR, pyrosequencer, molecular chiper. In immnulogical field, FIRST developes series of direct and indirect chemiluminascent immunoassayers. On its innovative assay instruments FIRST develops more than 300 assay kits, mainly for pharmacogenetical, pathogenic mocrobes, DNA methylation and various clinical fields. Many are unque in market.
Based on its innovative and high-technology, FIRST has been certified as "National Specified Redinement Differential Innovation enterprise of China", "National High-tech& Innovative Enterprise of China", IPO Gold-seed Enterprise of Hubei Province" and many other honors. FIRST has more than 50 Invention patents both in China and abroad.
MAIN PRODUCTS
OUR SERVICES
Molecular test
Drug gene combination coverage
Microbial identification
Methylation detection
Pathogen detection
reproductive health
Immunoassay
Cardiovascular: anticoagulation, blood lipid
High homocysteine risk and its prevention
Treatment evaluation
Scientific research
Open scientific research platform for customers
Customized project solution
Health management
Establishment of early risk assessment system for multiple diseases
Integrated health guidance program
NEWS CENTER
Health management refers to a process of comprehensive management of individual or population health risk factors.
2021-06-29
People with low immunity are susceptible to cancer: the occurrence, development, recurrence rate and survival period of tumors are closely related to the immune status of the body.
2021-06-29
Talking｜The status quo of molecular diagnostic technology
Molecular diagnosis is a technology that applies molecular biology methods to detect changes in the structure or expression level of the subject or the genetic material carrying viruses or pathogens, and to make a diagnosis based on the test results.
2021-06-29
China Economic Herald and China Development Network News reporter Qiu Aiquan reported in Shanghai June 27-28, initiated by the Shanghai Association for Science and Technology
2021-06-29
OUR HONOR
